Stock Price
701.60
Daily Change
-20.80 -2.88%
Monthly
0.52%
Yearly
16.39%
Q1 Forecast
704.56

argenx SE reported $336.29M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AstraZeneca USD 4.61B 4.46B Dec/2025
Galapagos EUR 34.55M 3.88M Sep/2025
Genmab DKK 144M 18M Jun/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 284.99M 2.24M Sep/2025
Hikma Pharmaceutical USD 139M 149M Jun/2025
Qiagen NV USD 153.88M 10.77M Dec/2025
UCB EUR 1.29B 221M Dec/2024